10.26.23 -- 5 Best Practices For Responding To FDA Form 483 Inspection Observations

It’s no secret that finding pharma/biotech manufacturing talent is challenging, and the lack of workers is having a negative impact on productivity and growth. Here are four effective strategies for recruiting, training, educating, and retaining your workforce.

To navigate these turbulent economic waters effectively, we must view this funding crunch as a push for creativity and resiliency. This present moment requires a strategy integrating savvy financial management and strategic vendor selection to ensure a thriving biotech.

How you respond to FDA Form 483 observations will determine if they escalate into more serious consequences, such as a warning letter or enforcement action. You don't want that. Follow this five-step action plan to make sure the findings are properly addressed.

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.